Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengxuebao Heji
- Development stage
- Phase 4
- Lead developer
- Hebei Shengxue Dacheng
- Administration
- Oral
01
Overview
Shengxuebao Heji is a Traditional Chinese Medicine (TCM) herbal mixture developed and manufactured by Xi'an Happiness Pharmaceutical. It is formulated to tonify the liver and kidney while nourishing qi and blood, addressing systemic deficiencies often seen in chronic illness or following aggressive medical treatments. The mixture is clinically indicated for the treatment of iron deficiency anemia and leukopenia, particularly as supportive therapy for patients experiencing bone marrow suppression (leukopenia and pancytopenia) resulting from chemotherapy or radiotherapy. Its composition includes several key botanical ingredients such as processed *Polygonum multiflorum*, *Ligustrum lucidum*, *Eclipta prostrata*, *Morus alba*, and *Astragalus membranaceus*, which are traditionally used to stimulate hematopoiesis and enhance immune function.
- Brand names
- ShengxuebaoTsinghua Deren
- Other names
- Shengxuebao MixtureSheng Xue Bao He JiTsinghua Deren Shengxuebao Heji
02
Targets
GRB2 (Growth factor receptor-bound protein 2)PIK3R1 (Phosphatidylinositol 4-phosphate 3-kinase regulatory subunit alpha)SRC (Proto-oncogene tyrosine-protein kinase Src)STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on Shengxuebao Heji.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shengxuebao Heji.